eClinical Technology and Industy News

How Dexcom CEO Kevin Sayer is leading the company forward

Excerpt from the Article:

Like most companies in 2020, Dexcom (NSDQ:DXCM) faced a number of challenges brought on by COVID-19, public unrest and more.

Dexcom chairman, president & CEO Kevin Sayer had to prioritize the health of his employees over all else, while also keeping patients safe and somehow managing to keep the diabetes giant rolling as a business.

“Anybody who says they’re prepared for something like this, they’re better than me,” Sayer told Medical Design & Outsourcing. “I think we’re just learning as we go.”

Click the button below to continue reading the Article:

Continue Reading The Article

Discover What Sets TrialStat Apart From Ordinary EDC Platforms

Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?